• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

Galectin Therap(GALT.US)

Overview
News
Financials
© 2026 Longbridge|Disclaimer

Event Tracking

Dec18
Fund L.P. 10X Sells Galectin Therapeutics Shares
16:44
Dec5
Galectin Therapeutics Inc. Releases New Data on Galectin-3 Inhibitor Belapectin
21:15
Nov15
Galectin Therap released FY2025 Q3 earnings on November 14 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.128 (forecast USD -0.11)
04:00
Galectin Therap released FY2025 9 Months earnings on November 14 (EST), actual revenue USD 0, actual EPS USD -0.4015
04:00
Nov10
Galectin Therapeutics Reports Positive Results for Belapectin in MASH Liver Disease 2b Phase NAVIGATE Trial
12:57
Aug15
Galectin Therap released FY2025 Semi-Annual earnings on August 14 (EST), actual revenue USD 0, actual EPS USD -0.2714
03:00

Schedules & Filings

Schedules
Filings
Nov14
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -8.223 M, EPS -0.128

Aug14
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -7.584 M, EPS -0.1195

May15
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -9.605 M, EPS -0.1519

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
INBS
9.530
+132.44%
+5.430
ANGH
3.770
+62.50%
+1.450
WTO
1.020
+61.09%
+0.387
ESHAR
0.2500
+47.06%
+0.080
NCL
0.2731
+40.77%
+0.079
FGMCR
0.5500
+33.50%
+0.138
ESHA
19.180
+33.38%
+4.800
IPEXR
0.8000
+31.97%
+0.194
RDACR
0.2400
+26.32%
+0.050
DVLT
0.6521
+26.25%
+0.136
View More